<p>Antibodies reactive against (A) the ecto-domain of the WNV E protein, and (B) inactivated WNV were measured in the individual animals at indicated time points. Humoral responses were quantified as sample:negative ratio (S/N). Vaccine-induced neutralizing capacity (PRNT50) of macaque sera was determined using the plaque reduction neutralization test (C). Individual animals are depicted as dots: group 1 (red), group 2 (green), and group 3 (blue). The median value is indicated for each group. Unpaired t-test was used to compare the responses between the groups. Statistical significant differences were defined as p<0.05 and are indicated with arches in the figure.</p
<p>Neutralising antibody activity against SIVsmE660 propagated on human C8166 cells in sera from mac...
<p>Anti-F4 (A) and anti-MV (B) antibody responses measured by ELISA with results given as mid-point ...
<p>Serum was collected from WT and <i>db/db</i> mice at indicated time points and WNV-specific (A) I...
<p>The data are shown as individual animal responses (circles) or as the mean antibody units for eac...
(A) Macaques (n = 8 per group) were vaccinated with quadrivalent WPV or SV formulations. A second do...
<p>Rhesus macaques (n = 5) were given 3 immunizations with the tetravalent vaccine formulated with e...
Sera collected before and after DENV challenge were tested for their concentration in the indicated ...
(A) Volcano plots of 17 humoral immune parameters following either one (SV or WPV) or two doses (SV⇢...
<p>Sera were collected in the indicated weeks after the first vaccination. Sera of week 2 were obtai...
<p><b>Panel A:</b> Antibody titers against the major capsid protein of MnPV were measured by VLP-ELI...
<p>Anti-Env IgG antibody titers were determined in plasma of control (<b>A</b>) and vaccinated (<b>B...
<p>(A) TCLA SIVmac251 neutralizing antibody titers in serum on the day of challenge inversely correl...
(A) Macaques (n = 3 per group) were infected with A/Yokohama/91/2007 (H1N1) and 56 days later vaccin...
<p>Macaque samples (analyzed as purified IgG) are arranged in the left-most column according to the ...
<p>Cynomolgus macaques were subcutaneously immunized twice (in weeks 0 and 2) with a whole virus par...
<p>Neutralising antibody activity against SIVsmE660 propagated on human C8166 cells in sera from mac...
<p>Anti-F4 (A) and anti-MV (B) antibody responses measured by ELISA with results given as mid-point ...
<p>Serum was collected from WT and <i>db/db</i> mice at indicated time points and WNV-specific (A) I...
<p>The data are shown as individual animal responses (circles) or as the mean antibody units for eac...
(A) Macaques (n = 8 per group) were vaccinated with quadrivalent WPV or SV formulations. A second do...
<p>Rhesus macaques (n = 5) were given 3 immunizations with the tetravalent vaccine formulated with e...
Sera collected before and after DENV challenge were tested for their concentration in the indicated ...
(A) Volcano plots of 17 humoral immune parameters following either one (SV or WPV) or two doses (SV⇢...
<p>Sera were collected in the indicated weeks after the first vaccination. Sera of week 2 were obtai...
<p><b>Panel A:</b> Antibody titers against the major capsid protein of MnPV were measured by VLP-ELI...
<p>Anti-Env IgG antibody titers were determined in plasma of control (<b>A</b>) and vaccinated (<b>B...
<p>(A) TCLA SIVmac251 neutralizing antibody titers in serum on the day of challenge inversely correl...
(A) Macaques (n = 3 per group) were infected with A/Yokohama/91/2007 (H1N1) and 56 days later vaccin...
<p>Macaque samples (analyzed as purified IgG) are arranged in the left-most column according to the ...
<p>Cynomolgus macaques were subcutaneously immunized twice (in weeks 0 and 2) with a whole virus par...
<p>Neutralising antibody activity against SIVsmE660 propagated on human C8166 cells in sera from mac...
<p>Anti-F4 (A) and anti-MV (B) antibody responses measured by ELISA with results given as mid-point ...
<p>Serum was collected from WT and <i>db/db</i> mice at indicated time points and WNV-specific (A) I...